Cencora to buy retina business of EyeSouth Partners for $1.1 billion

Cencora will acquire EyeSouth Partners' retina business for $1.1 billion to expand its eye-care unit. The acquisition should modestly enhance Cencora's specialty healthcare revenue and strategic footprint in ophthalmology; the $1.1B price is meaningful for the unit but modest relative to Cencora's overall scale. Integration and execution risk remain the primary near-term considerations.

Analysis

Cencora will acquire EyeSouth Partners' retina business for $1.1 billion to expand its eye-care unit. The acquisition should modestly enhance Cencora's specialty healthcare revenue and strategic footprint in ophthalmology; the $1.1B price is meaningful for the unit but modest relative to Cencora's overall scale. Integration and execution risk remain the primary near-term considerations.